Exosomes:From biogenesis and secretion to the early pathogenesis of Alzheimer's disease

外泌体:从生物发生和分泌到阿尔茨海默病的早期发病机制

基本信息

  • 批准号:
    9421411
  • 负责人:
  • 金额:
    $ 40.88万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-09-15 至 2022-05-31
  • 项目状态:
    已结题

项目摘要

ABSTRACT Bi-directional communication between astrocytes and neurons regulates synaptic formation, synaptic strength, and participates in the regulation of neural circuitry by coordinating activity among groups of neurons. Astrocyte dysfunction in Alzheimer’s (AD), and other neurodegenerative conditions has been postulated to contribute to perturbations in activity of neural networks involved in memory and executive functions. Although AD associated modifications in the composition and quantity of various cytokine, chemokine and growth factors released from astrocytes have been demonstrated, these observations have thus far been insufficient to explain how astrocyte stress contributes to neuronal dysfunction. Advancements in our understanding of the biology of extracellular vesicles have begun to implicate glial released microvesicles as primary mediators of glia to neuron communication. In preliminary experiments we provide evidence that a variety of stimuli can induce astrocytes to shed microvesicles. The molecular cargo of these astrocyte-shed microvesicles was complex, and contained more than 200 distinct proteins, 100 miRNA, and hundreds of bioreactive lipid species. Moreover, the protein, miRNA and lipid composition of astrocyte exosomes was modified by the stimulus used to induce release and could be further modified by pre-treatment with oligomeric A peptides. These astrocyte- shed exosomes directly interacted with neurons to modify neuronal structure and function. Based on these preliminary findings we reasoned that a scientific focus on any one protein, lipid or miRNA would be unlikely to produce a true representation of the functions regulated by this complex signaling vesicles. Therefore, we used bioinformatic and systems biology approaches to understand how the protein, miRNA and lipid composition of exosomes interacts to regulate neuronal signaling pathways identified by whole genome sequencing of target neurons. In this application we focused our efforts on a small number of the identified pathways. In particular we concentrated on neural pathways associated with synapse formation, spine formation, and neurite outgrowth, as these neuronal structures are damaged in AD. The goals of this application are to understand how endogenous excitatory stimuli and inflammatory stimuli associated with AD modulate the cargo of astrocyte-shed exosomes and how these exosomes regulate/dysregulate the structure and function of target neurons.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Norman J Haughey其他文献

Norman J Haughey的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Norman J Haughey', 18)}}的其他基金

A Sphingomyelin Hydrolase Regulates the Late Stages of HIV Assembly and Budding
鞘磷脂水解酶调节 HIV 组装和出芽的后期阶段
  • 批准号:
    10548445
  • 财政年份:
    2022
  • 资助金额:
    $ 40.88万
  • 项目类别:
A Sphingomyelin Hydrolase Regulates the Late Stages of HIV Assembly and Budding
鞘磷脂水解酶调节 HIV 组装和出芽的后期阶段
  • 批准号:
    10665753
  • 财政年份:
    2022
  • 资助金额:
    $ 40.88万
  • 项目类别:
NLRP inflammasome directed activation of the innate immune system produces synaptic damage in EcoHIV infected mice self-administering fentanyl
NLRP 炎性体定向激活先天免疫系统,在 EcoHIV 感染小鼠自我施用芬太尼时产生突触损伤
  • 批准号:
    10085923
  • 财政年份:
    2020
  • 资助金额:
    $ 40.88万
  • 项目类别:
NLRP inflammasome directed activation of the innate immune system produces synaptic damage in EcoHIV infected mice self-administering fentanyl
NLRP 炎性体定向激活先天免疫系统,在 EcoHIV 感染小鼠自我施用芬太尼时产生突触损伤
  • 批准号:
    10402833
  • 财政年份:
    2020
  • 资助金额:
    $ 40.88万
  • 项目类别:
NLRP inflammasome directed activation of the innate immune system produces synaptic damage in EcoHIV infected mice self-administering fentanyl
NLRP 炎性体定向激活先天免疫系统,在 EcoHIV 感染小鼠自我施用芬太尼时产生突触损伤
  • 批准号:
    10202547
  • 财政年份:
    2020
  • 资助金额:
    $ 40.88万
  • 项目类别:
NLRP inflammasome directed activation of the innate immune system produces synaptic damage in EcoHIV infected mice self-administering fentanyl
NLRP 炎性体定向激活先天免疫系统,在 EcoHIV 感染小鼠自我施用芬太尼时产生突触损伤
  • 批准号:
    10612471
  • 财政年份:
    2020
  • 资助金额:
    $ 40.88万
  • 项目类别:
Exosomes:From biogenesis and secretion to the early pathogenesis of Alzheimer's disease
外泌体:从生物发生和分泌到阿尔茨海默病的早期发病机制
  • 批准号:
    10183120
  • 财政年份:
    2017
  • 资助金额:
    $ 40.88万
  • 项目类别:
Dysregualtion of gliotransmission in models of neuroHIV
神经艾滋病毒模型中神经胶质细胞传递失调
  • 批准号:
    9135858
  • 财政年份:
    2016
  • 资助金额:
    $ 40.88万
  • 项目类别:
Dysregualtion of gliotransmission in models of neuroHIV
神经艾滋病毒模型中神经胶质细胞传递失调
  • 批准号:
    9258500
  • 财政年份:
    2016
  • 资助金额:
    $ 40.88万
  • 项目类别:
'Intranasal Insulin Therapy for HIV- Associated Neurocognitive Disorders'
“鼻内胰岛素治疗 HIV 相关神经认知障碍”
  • 批准号:
    9762158
  • 财政年份:
    2015
  • 资助金额:
    $ 40.88万
  • 项目类别:

相似海外基金

Environmental copper exposure and its impact on microglial Abeta clearance
环境铜暴露及其对小胶质细胞 Abeta 清除的影响
  • 批准号:
    8757425
  • 财政年份:
    2014
  • 资助金额:
    $ 40.88万
  • 项目类别:
Development of Novel Therapies for AD Targeting Abeta Clearance
针对 Abeta 清除的 AD 新型疗法的开发
  • 批准号:
    8820188
  • 财政年份:
    2014
  • 资助金额:
    $ 40.88万
  • 项目类别:
Development of Novel Therapies for AD Targeting Abeta Clearance
针对 Abeta 清除的 AD 新型疗法的开发
  • 批准号:
    9040023
  • 财政年份:
    2014
  • 资助金额:
    $ 40.88万
  • 项目类别:
Environmental copper exposure and its impact on microglial Abeta clearance
环境铜暴露及其对小胶质细胞 Abeta 清除的影响
  • 批准号:
    8930156
  • 财政年份:
    2014
  • 资助金额:
    $ 40.88万
  • 项目类别:
Caloric restriction and Alzheimers ABeta clearance pathway
热量限制和阿尔茨海默病 Aβ 清除途径
  • 批准号:
    8897941
  • 财政年份:
    2013
  • 资助金额:
    $ 40.88万
  • 项目类别:
Caloric restriction and Alzheimers ABeta clearance pathway
热量限制和阿尔茨海默病 Aβ 清除途径
  • 批准号:
    8411069
  • 财政年份:
    2013
  • 资助金额:
    $ 40.88万
  • 项目类别:
Caloric restriction and Alzheimers ABeta clearance pathway
热量限制和阿尔茨海默病 Aβ 清除途径
  • 批准号:
    8713897
  • 财政年份:
    2013
  • 资助金额:
    $ 40.88万
  • 项目类别:
The role of human ApoE in soluble ABeta clearance through the LDLR in vivo
人 ApoE 在体内通过 LDLR 清除可溶性 Aβ 中的作用
  • 批准号:
    7752282
  • 财政年份:
    2009
  • 资助金额:
    $ 40.88万
  • 项目类别:
The role of human ApoE in soluble ABeta clearance through the LDLR in vivo
人 ApoE 在体内通过 LDLR 清除可溶性 Aβ 中的作用
  • 批准号:
    8090296
  • 财政年份:
    2009
  • 资助金额:
    $ 40.88万
  • 项目类别:
Development of therapeutics for dementia targeting Abeta clearance
开发针对 Abeta 清除的痴呆疗法
  • 批准号:
    20590697
  • 财政年份:
    2008
  • 资助金额:
    $ 40.88万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了